+44-77-2385-9429Rheumatology: Current Research : Citations & Metrics Report
Articles published in Rheumatology: Current Research have been cited by esteemed scholars and scientists all around the world. Rheumatology: Current Research has got h-index 17, which means every article in Rheumatology: Current Research has got 17 average citations.
Following are the list of articles that have cited the articles published in Rheumatology: Current Research.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
60 | 56 | 30 | 60 | 41 | 12 | 15 | 19 |
Conference proceedings |
0 | 0 | 0 | 0 | 0 | 0 | 34 | 24 |
Citations received as per Google Scholar, other indexing platforms and portals |
232 | 238 | 254 | 246 | 173 | 150 | 146 | 152 |
| Journal total citations count | 2294 |
| Journal impact factor | 2.82 |
| Journal 5 years impact factor | 3.38 |
| Journal cite score | 3.26 |
| Journal h-index | 17 |
| Journal h-index since 2019 | 12 |
Important citations (516)
Bioactive plasma mitochondrial dna is associated with disease progression in scleroderma?associated interstitial lung disease |
|
Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease |
|
Musculoskeletal examination: education and training for current and future needs of healthcare provision |
|
Stem cell therapy for the treatment of cartilage defects and osteoarthritis |
|
Reserve or resident progenitors in cartilage? comparative analysis of chondrocytes versus chondroprogenitors and their role in cartilage repair. |
|
Fibrin scaffolds designing in order to human adipose-derived mesenchymal stem cells differentiation to chondrocytes in the presence of tgf-?3 |
|
Progression of gastrointestinal symptoms over time in patients with systemic sclerosis |
|
Functional autoantibodies targeting g protein-coupled receptors in rheumatic diseases. |
|
Intestinal involvement in systemic sclerosis: a clinical review. |
|
Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and ph metric features: a prospective comparative hospital based study |
|
Evaluation of risk factors for pseudo-obstruction in systemic sclerosis. |
|
Lung transplantation in systemic sclerosis: a practice survey of united states lung transplant centers. |
|
High proton pump inhibitor exposure increases risk of calcinosis in systemic sclerosis. |
|
Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis |
|
Responsiveness of the university of california los angeles scleroderma clinical trial consortium gastrointestinal tract 2.0 (ucla-sctc-git 2.0)to change in scleroderma patients: |
|
The burning question: to use or not to use cyclophosphamide in systemic sclerosis. |
|
Anti-vinculin antibodies in scleroderma (ssc): a potential link between autoimmunity and gastrointestinal system involvement in two ssc cohorts |
|
Patient-reported outcome instruments in clinical trials of systemic sclerosis: |
|
Safety and efficacy of faecal microbiota transplantation by anaerobic cultivated human intestinal microbiome (achim) in patients with systemic sclerosis: study protocol for the randomised controlled phase ii resscue trial. |
|
Patient perception of disease burden in diffuse cutaneous systemic sclerosis |
|